美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=NDA203312"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
64896-661-99 64896-661 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 23.75 mg/1; 95 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-99)
64896-662-01 64896-662 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 36.25 mg/1; 145 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-01)
64896-662-09 64896-662 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 36.25 mg/1; 145 mg/1 25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-09)
64896-662-43 64896-662 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 36.25 mg/1; 145 mg/1 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-43)
64896-662-99 64896-662 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 36.25 mg/1; 145 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-662-99)
64896-663-01 64896-663 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 48.75 mg/1; 195 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-663-01)
64896-663-09 64896-663 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 48.75 mg/1; 195 mg/1 25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-663-09)
64896-663-43 64896-663 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 48.75 mg/1; 195 mg/1 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-663-43)
64896-663-99 64896-663 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 48.75 mg/1; 195 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-663-99)
64896-664-01 64896-664 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 61.25 mg/1; 245 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-664-01)
64896-664-43 64896-664 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 61.25 mg/1; 245 mg/1 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-664-43)
64896-661-43 64896-661 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 23.75 mg/1; 95 mg/1 240 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-43)
64896-661-09 64896-661 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 23.75 mg/1; 95 mg/1 25 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-09)
64896-661-01 64896-661 HUMAN PRESCRIPTION DRUG RYTARY Carbidopa and Levodopa CAPSULE, EXTENDED RELEASE ORAL 20150112 N/A NDA NDA203312 Amneal Pharmaceuticals LLC CARBIDOPA; LEVODOPA 23.75 mg/1; 95 mg/1 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (64896-661-01)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase